what drug is tirzepatide for Weight Loss Tirzepatide vs. Semaglutide: Which Weight

References Forman HJ, Zhang H, Rinna A

For more information on VINCI protocols, please refer to the VHA website: (or if accessing via VHA intranet)

Welcome to our blog

Health Canada typically reviews new drug applications following FDA approval, adding 6-18 months to Canadian availability timelines

Regulatory and Compliance Notes FDA Status: While tirzepatide is FDA-approved as Mounjaro (for T2DM) and Zepbound (for weight loss and obstructive sleep apnea) in clinical settings, this 10 mg research-grade peptide is not approved for therapeutic use

The study measured weight loss at two points: 24 weeks and 48 weeks